#Pelthos #Xeglyze #Biopharmaceuticals
www.benzinga.com
Pelthos Therapeutics Acquires Xeglyze庐 (abametapir) Topical Treatment for Head Lice - Pelthos Therapeutics (AMEX:PTHS)
Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and older
DURHAM, N.
#Pelthos #Xeglyze #Biopharmaceuticals
www.benzinga.com
Pelthos Therapeutics Acquires Xeglyze庐 (abametapir) Topical Treatment for Head Lice - Pelthos Therapeutics (AMEX:PTHS)
Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and older
DURHAM, N.
#Pelthos #Xeglyze #Biopharmaceuticals
www.benzinga.com
Pelthos Therapeutics Acquires Xeglyze庐 (abametapir) Topical Treatment for Head Lice - Pelthos Therapeutics (AMEX:PTHS)
Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and older
DURHAM, N.
